These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15758474)

  • 21. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats.
    Mori A; Saito M; Sakamoto K; Narita M; Nakahara T; Ishii K
    Eur J Pharmacol; 2007 Sep; 570(1-3):135-41. PubMed ID: 17628525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
    Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the agonist activity of prostacyclin analogues on prostanoid EP4 receptors using GW 627368 and taprostene: evidence for species differences.
    Jones RL; Chan KM
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):289-99. PubMed ID: 15763441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms involved in skeletal anabolic therapies.
    Martin TJ; Quinn JM; Gillespie MT; Ng KW; Karsdal MA; Sims NA
    Ann N Y Acad Sci; 2006 Apr; 1068():458-70. PubMed ID: 16831943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The benefit of combining non-mechanical agents with mechanical loading: a perspective based on the Utah Paradigm of Skeletal Physiology.
    Jee WS; Tian XY
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):110-8. PubMed ID: 15951626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gi-coupled prostanoid receptors are the likely targets for COX-1-generated prostanoids in rat pheochromocytoma (PC12) cells.
    Yung HS; Chow KB; Lai KH; Wise H
    Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):65-71. PubMed ID: 19497718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.
    Hagino H; Kuraoka M; Kameyama Y; Okano T; Teshima R
    Bone; 2005 Mar; 36(3):444-53. PubMed ID: 15777678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactams as prostanoid receptor ligands. Part 4: 2-Piperidones as selective EP4 receptor agonists.
    Elworthy TR; Brill ER; Caires CC; Kim W; Lach LK; Tracy JL; Chiou SS
    Bioorg Med Chem Lett; 2005 May; 15(10):2523-6. PubMed ID: 15863309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma.
    Hori R; Nakagawa T; Sugimoto Y; Sakamoto T; Yamamoto N; Hamaguchi K; Ito J
    Neuroscience; 2009 Jun; 160(4):813-9. PubMed ID: 19303430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostanoid receptors and the urogenital tract.
    Breyer MD; Hébert RL; Breyer RM
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1343-53. PubMed ID: 14758774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgens and bone.
    Vanderschueren D; Gaytant J; Boonen S; Venken K
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):250-4. PubMed ID: 18438173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel prostaglandin analogs of PGE2 as potent and selective EP2 and EP4 receptor agonists.
    Xiao Y; Araldi GL; Zhao Z; Brugger N; Karra S; Fischer D; Palmer E
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4323-7. PubMed ID: 17531488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D; Cornish J
    Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity.
    Weinreb M; Shamir D; Machwate M; Rodan GA; Harada S; Keila S
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):81-90. PubMed ID: 16890416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteocyte-mediated mechanical response controls osteoblast differentiation and function.
    Buck HV; Stains JP
    Front Physiol; 2024; 15():1364694. PubMed ID: 38529481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fever.
    Bartfai T; Conti B
    ScientificWorldJournal; 2010 Mar; 10():490-503. PubMed ID: 20305990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E(2) receptors in bone formation.
    Li M; Thompson DD; Paralkar VM
    Int Orthop; 2007 Dec; 31(6):767-72. PubMed ID: 17593365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone anabolic therapy with selective prostaglandin analogs.
    Hartke JR; Lundy MW
    J Musculoskelet Neuronal Interact; 2001 Sep; 2(1):25-31. PubMed ID: 15758474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
    Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
    Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.